靶向PPARγ的miRNA在冠脉支架内再狭窄中的表达及意义
DOI:
作者:
作者单位:

( 1.济宁医学院附属医院 心内科,;2.济宁医学院附属医院 心外科,;3. 山东省心脏疾病诊疗重点实验室,山东省济宁市 272029)

作者简介:

张韶辉,博士,主治医师,研究方向为miRNA与冠心病,E-mail为zhangshaohui9@sina.com。

通讯作者:

基金项目:

山东省医药卫生科技发展项目(2014WS0515);济宁医学院重点项目(JY2013KJ005)


Expression and significance of the miRNAs target to PPARγ in coronary artery in-stent restenosis
Author:
Affiliation:

1. Department of Cardiology, ;2. Department of Cardiac Surgery, ;3. Shandong Provinicial Key Laboratory of Cardiac Disease Diagnosis and Treatment, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探索靶向于过氧化体增殖物激活型受体γ(PPARγ)的miRNA,在这些miRNA中寻找与支架内再狭窄(ISR)密切相关的miRNA,并初步探索其临床意义。 方法 利用Cytoscape及其插件构建miRNA与PPARγ的作用网络,筛选出靶向PPARγ的关键miRNA。利用实时荧光定量聚合酶链反应(Real-time PCR)检测这部分miRNA在ISR人群中的表达差异,再通过ROC曲线评估miRNA对ISR患者的临床识别能力。 结果 通过生物信息学分析发现,miR-27a/b对PPARγ的调控作用较强;而miR-130a/b则能调控该网络中更多的基因。Real-time PCR发现miR-27a/b和miR-130a在ISR组较non-ISR组存在差异性表达(P<0.05)。ROC曲线分析发现,miR-27a对ISR具有一定的临床识别能力(AUC =0.884,95% CI 0.768~1.00,P<0.001)。 结论 miR-27a/b和miR-130a/b是靶向于PPARγ的主要miRNA,miR-27a/b和miR-130a在ISR中差异性表达,miR-27a可能对识别ISR患者具有一定的临床意义。

    Abstract:

    Aim To explore the key members of the miRNAs target to peroxisome proliferator-activated receptor γ(PPARγ), and reveal the clinical significance of which are closely related to in-stent restenosis(ISR). Methods Cytoscape and its plug-in was used to build the miRNAs-PPAR regulatory network to screen out which are the key miRNAs target to PPARγ. The expression of miRNAs in ISR group were detected by Real-time PCR and the clinical recognition ability of miRNAs on ISR patients were evaluated by ROC curve. Results By bioinformatics analysis, miR-27a/b has a strong regulatory effect on PPARγ, while miR-130a/b is able to regulate more genes in the network. Real-time PCR found that miR-27a/b and miR-130a were differentially expressed in the ISR group and no-ISR group (P<0.05). ROC curve analysis showed that miR-27a has a certain clinical recognition ability to ISR (AUC =0.4,5% CI 0.768~1.00, P<0.001). Conclusion MiR-27a/b and miR-130a/b are key members of the miRNAs target to PPARγ, miR-27a/b and miR-130a were differentially expressed in ISR, miR-27a might have certain clinical diagnostic value in patients with ISR.

    参考文献
    相似文献
    引证文献
引用本文

张韶辉,赵永亮,魏广和,刘立新,杨国良,高振才,蔺跃栋,郭莹.靶向PPARγ的miRNA在冠脉支架内再狭窄中的表达及意义[J].中国动脉硬化杂志,2017,25(6):582~589.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2016-10-11
  • 最后修改日期:2017-01-19
  • 录用日期:
  • 在线发布日期: 2017-06-05